Daniel Sehrt

608 total citations
12 papers, 252 citations indexed

About

Daniel Sehrt is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel Sehrt has authored 12 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel Sehrt's work include Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer-related Molecular Pathways (2 papers). Daniel Sehrt is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer-related Molecular Pathways (2 papers). Daniel Sehrt collaborates with scholars based in Germany, United States and Denmark. Daniel Sehrt's co-authors include Mladen V. Tzvetkov, Jürgen Brockmöller, Ingolf Meineke, Stefan Viktor Vormfelde, Jennifer Gile, Tobias Eckle, Eric Leibing, Yoshimasa Oyama, Suren A. Tatulian and Khatereh Motamedchaboki and has published in prestigious journals such as Cell Metabolism, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Daniel Sehrt

12 papers receiving 246 citations

Peers

Countries citing papers authored by Daniel Sehrt

Since Specialization

Citations

This map shows the geographic impact of Daniel Sehrt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sehrt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sehrt more than expected).

Fields of papers citing papers by Daniel Sehrt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sehrt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sehrt. The network helps show where Daniel Sehrt may publish in the future.

Co-authorship network of co-authors of Daniel Sehrt

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Sehrt. A scholar is included among the top collaborators of Daniel Sehrt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Sehrt. Daniel Sehrt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans 2020 ·Frontiers in Genetics ·Johannes Matthaei, Wagner Hugo Bonat, Reinhold Kerb, Mladen V. Tzvetkov, (unknown), (unknown), (unknown), Daniel Sehrt, Ute Hofmann, Jacob Hjelmborg, Matthias Schwab, Jürgen Brockmöller	17
2	The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury 2018 ·Current Pharmaceutical Design ·Yoshimasa Oyama, (unknown), Jennifer Gile, Daniel Sehrt, Tobias Eckle	18
3	Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters 2016 ·Genome Medicine ·Johannes Matthaei, Mladen V. Tzvetkov, (unknown), (unknown), Daniel Sehrt, Jacob Hjelmborg, Ute Hofmann, Matthias Schwab, Reinhold Kerb, Jürgen Brockmöller	10
4	The Dual Pathway Inhibitor Rigosertib Is Effective in Direct Patient Tumor Xenografts of Head and Neck Squamous Cell Carcinomas 2013 ·Molecular Cancer Therapeutics ·Ryan T. Anderson, Stephen B. Keysar, Daniel W. Bowles, Magdalena J. Glogowska, David P. Astling, J. Jason Morton, Phuong N. Le, (unknown), (unknown), Gregory N. Gan, Brian W. Vogler, Daniel Sehrt, (unknown), Dara L. Aisner, François Wilhelm, Barbara Frederick, Marileila Varella‐Garcia, Aik Choon Tan, Antonio Jimeno	20
5	C2 Domain-Containing Phosphoprotein CDP138 Regulates GLUT4 Insertion into the Plasma Membrane 2011 ·Cell Metabolism ·Xiangyang Xie, Zhenwei Gong, Virginie Mansuy‐Aubert, Qiong Zhou, Suren A. Tatulian, Daniel Sehrt, Florian Gnad, Laurence M. Brill, Khatereh Motamedchaboki, Yu Chen, Michael Czech, Matthias Mann, Marcus Krüger, Zhen Jiang	47
6	Abstract 652: PI3K inhibition combined with either cetuximab or docetaxel in a direct patient tumor model of HPV-positive and negative head and neck cancers 2011 ·Cancer Research ·Daniel W. Bowles, Stephen B. Keysar, Ryan T. Anderson, Daniel Sehrt, (unknown), John I. Song, Diana F. Hausman, Scott Peterson, Antonio Jimeno	4
7	Carvedilol Pharmacokinetics and Pharmacodynamics in Relation to CYP2D6 and ADRB Pharmacogenetics 2011 ·Pharmacogenomics ·Daniel Sehrt, Ingolf Meineke, Mladen V. Tzvetkov, (unknown), Jürgen Brockmöller	47
8	Amelogenin-Based Sex Identification as a Strategy to Control the Identity of DNA Samples in Genetic Association Studies 2010 ·Pharmacogenomics ·Mladen V. Tzvetkov, Ingolf Meineke, Daniel Sehrt, Stefan Viktor Vormfelde, Jürgen Brockmöller	20
9	Bioinformatic and functional analysis of TGFBR1 polymorphisms 2009 ·Pharmacogenetics and Genomics ·Markus Schirmer, (unknown), (unknown), (unknown), (unknown), Marion Hoffmann, (unknown), Daniel Sehrt, Mladen V. Tzvetkov, Margret Rave‐Fränk, Jürgen Brockmöller	5
10	Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers 2009 ·Clinical Research in Cardiology ·Wolfgang Schillinger, (unknown), Nils Teucher, Samuel Sossalla, Daniel Sehrt, Klaus Jung, Mark Hünlich, Bernhard Unsöld, (unknown), Giuliano Ramadori, Reinhard Hilgers, Harald Schwörer, Gerd Hasenfuß	9
11	Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers 2006 ·European Journal of Clinical Pharmacology ·Stefan Viktor Vormfelde, Daniel Sehrt, (unknown), (unknown), Mladen V. Tzvetkov, Jürgen Brockmöller	24
12	Anxiety- and novelty seeking-related personality traits and serotonin transporter gene polymorphisms 2005 ·Journal of Psychiatric Research ·Stefan Viktor Vormfelde, (unknown), Mladen V. Tzvetkov, (unknown), Daniel Sehrt, Jürgen Brockmöller, Eric Leibing	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact